Jazz Pharmaceuticals Plc (JAZZ)

09:43 AM

Jazz Pharmaceuticals (JAZZ) Highlights Growth at Goldman Sachs Healthcare Conference - MSN

09:43 AM

06:50 AM

What analysts say about Jazz Pharmaceuticals plc stockFree Stock Market Trend Analysis - Autocar Professional

06:50 AM

04:09 AM

What drives Jazz Pharmaceuticals plc stock priceUnmatched market performance - Autocar Professional

04:09 AM

Jul 22, 2025

Jazz Pharmaceuticals plc Stock Analysis and ForecastRecord-setting profit potential - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is Jazz Pharmaceuticals plc a good long term investmentPhenomenal returns - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 5, 2025 - PR Newswire UK

Jul 22, 2025

Jul 21, 2025

Lacklustre Performance Is Driving Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) Low P/E - simplywall.st

Jul 21, 2025

Jul 18, 2025

Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com

Jul 18, 2025

Jul 17, 2025

Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 - GlobeNewswire Inc.

Jul 17, 2025

Jul 15, 2025

Jazz Pharmaceuticals Stock Offers Buying Opportunity After Slump, Deutsche Bank Says - MarketScreener

Jul 15, 2025

Jul 15, 2025

Jazz Pharmaceuticals (JAZZ) Receives Buy Rating from Deutsche Ba - GuruFocus

Jul 15, 2025

Jul 15, 2025

Deutsche Bank initiates Jazz Pharmaceuticals stock with Buy rating By Investing.com - Investing.com Nigeria

Jul 15, 2025

Jul 15, 2025

Deutsche Bank Initiates Jazz Pharmaceuticals at Buy With $152 Price Target - MarketScreener

Jul 15, 2025

Jul 14, 2025

What makes Jazz Pharmaceuticals plc stock price move sharplyFree Capital Allocation Plans - beatles.ru

Jul 14, 2025

Jul 14, 2025

Ireland: Renee Gala elected CEO at Jazz Pharma - Investors in Healthcare

Jul 14, 2025

Jul 11, 2025

Jazz names new CEO; Ultragenyx, Mereo shares slide on trial update - BioPharma Dive

Jul 11, 2025

Jul 11, 2025

Jazz Pharmaceuticals Appoints Renee Gala as New CEO - The Globe and Mail

Jul 11, 2025

Jul 11, 2025

Jazz Pharmaceuticals names Renee Gala as next CEO By Investing.com - Investing.com South Africa

Jul 11, 2025

Jul 11, 2025

Jazz Pharmaceuticals names Renee Gala as next CEO - Investing.com Australia

Jul 11, 2025

Jul 11, 2025

1 Profitable Stock with Solid Fundamentals and 2 to Brush Off - Yahoo Finance

Jul 11, 2025

Jul 10, 2025

Jazz Looks To Block Avadel From Asking For Sleep Drug OK - Law360

Jul 10, 2025

Jul 10, 2025

Avadel Pharmaceuticals Receives Unanimous Appeals Court Affirmation for LUMRYZ FDA Approval - Insider Monkey

Jul 10, 2025

Jul 10, 2025

Jazz Pharmaceuticals Names Renee Gala as President & CEO - Contract Pharma

Jul 10, 2025

Jul 10, 2025

Jazz Pharmaceuticals names Renee Gala as president and CEO - MarketScreener

Jul 10, 2025

Jul 10, 2025

Jazz Pharmaceuticals Names Renee Gala as President and Chief Executive Officer - PR Newswire

Jul 10, 2025

Jul 07, 2025

Jazz Pharmaceuticals Gets UBS Buy Rating After Strong ASCO 2025 Trial Results - MSN

Jul 07, 2025